Beth Israel Deaconess Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Beth Israel Deaconess Medical Center sits in the top decile of US sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count).
Beth Israel Deaconess Medical Center: 488 sponsored US clinical trials, 66 recruiting.
Beth Israel Deaconess Medical Center sponsors 488 registered US clinical trials on ClinicalTrials.gov, 66 of them currently recruiting, and 321 completed. 45 of these trials are in Phase 3-4 (later-stage) and 144 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 8 trials.
Top-decile sponsor footprint
Beth Israel Deaconess Medical Center ranks in the top decile of sponsors by registered trial count (#75 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
321 of 380 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
488 total, page 5 of 10
Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery
NCT03482973
EEG Changes With Guided Online Meditation
NCT03459690
Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening
NCT03482557
House Calls and Peer Mentorship
NCT03354910
Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening
NCT03495115
Clinical Decision Support Tools for Antibiotic Prescribing
NCT03580603
Measuring Skin Elasticity in Lymphedema Patients
NCT03313999
Adaptive Support Ventilation in Acute Respiratory Distress Syndrome
NCT03715751
Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial
NCT03389555
Living Kidney Donor Lost Wages Trial
NCT03268850
Moderate Alcohol and Cardiovascular Health Trial
NCT03169530
Guided Meditation as an Adjunct to Enhance Postoperative Recovery
NCT03198039
Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients
NCT03347656
Discussing Stopping Cancer Screening and Prognosis With Older Adults
NCT03480282
The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes
NCT02915263
Vitamin D Supplementation in IBS
NCT03148288
Mind Body Program for Fear of Recurrence
NCT03695406
The Effects of Increased Fructose Ingestion on FGF-21 Levels in Humans
NCT03201549
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
NCT02973139
Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
NCT05669066
Breast Cancer Risk Assessment in Women Aged 40-49
NCT03180086
Anesthetics to Prevent Lung Injury in Cardiac Surgery
NCT02918877
Managing Side Effects in Clinical Practice
NCT03475550
Thiamine vs. Placebo to Increase Oxygen Consumption After Cardiac Arrest
NCT02974257
A Study of Effects of Age and Hyperkyphosis on Spine Motion and Loading
NCT03008902
Brief Behavioral Treatment for Sleep Problems in IBS Study
NCT03087799
Optimizing HIV PrEP Through Shared Decision Making
NCT03019770
Mechanisms Underlying the Blood Pressure Lowering Effect of Sleep
NCT03043963
Safety and Clinical Outcomes of Magnetic Resonance Imaging in Patients With Cardiac Implantable Electrical Devices
NCT03016429
Prevention of Early Postoperative Decline
NCT02908464
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
NCT02739412
Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique
NCT02271100
Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa
NCT02805595
Surgical vs. Lifestyle in Obese Older Adults
NCT03137329
A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older
NCT02823262
Effects of Open-label vs Double-blind Treatment in IBS
NCT02802241
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
NCT02847481
The Evolution of Memories Across Wake and Sleep
NCT03227406
Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
NCT02934555
Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury
NCT02701127
Migraine and Homeostasis:What Can we Learn From Glucose
NCT03097536
FGF21 and Fructose Challenge in Humans
NCT02884791
Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
NCT02680704
Activation of Brain Centers by Short-term Walnut Consumption in Obesity
NCT02673281
Identification of L3-L4 Interspace in Parturients
NCT02697747
Memory Aid by Intranasal Insulin in Diabetes (MemAID)
NCT02415556
Dexmedetomidine and IV Acetaminophen for the Prevention of Postoperative Delirium Following Cardiac Surgery
NCT02546765
Computer-Aided Learning for Managing Stress
NCT02531243
Efficacy of Transversus Abdominis Plane (TAP) Block Techniques: Surgeon vs Anesthesia - Ultrasound Guidance
NCT03577912
Ultrasound Guided Femoral Nerve Block
NCT02381717
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 53 |
| Phase 2 | 91 |
| Phase 3 | 13 |
| Phase 4 | 32 |
Therapeutic Areas
What is open in the Beth Israel Deaconess Medical Center pipeline
66 recruiting of 488 indexed (14% open); 321 completed (66%).
Phase mix: 45 late (III/IV) vs 144 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Beth Israel Deaconess Medical Center: open-pipeline peers nationwide
Peers matched on 488 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Beth Israel Deaconess Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 488 trials (± recruiting share)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 490 trials · 10% recruiting
- Fred Hutchinson Cancer Center · 483 trials · 12% recruiting
- National Heart, Lung, and Blood Institute (NHLBI) · 501 trials · 12% recruiting
- H. Lee Moffitt Cancer Center and Research Institute · 502 trials · 16% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Wayne State University · 13% recruiting · 163 trials
- University of Michigan · 13% recruiting · 1,327 trials
- Albany Medical College · 13% recruiting · 52 trials
Related
What to do with this Beth Israel Deaconess Medical Center page
488 registered trials is a research-attention snapshot, not an endorsement of Beth Israel Deaconess Medical Center or any single study.
- 66 of Beth Israel Deaconess Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Beth Israel Deaconess Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Beth Israel Deaconess Medical Center pipeline card: 488 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.